Home > Press > Iranian Inventors Patent Special Wound Dressing with USPTO
Abstract:
Iranian pharmacists invented a nanostructured wound dressing which comprises active wound healing and antibacterial agents. The innovative method and its related product was granted a US patent on July 19, 2012.
Iranian Inventors Patent Special Wound Dressing with USPTO
Tehran, Iran | Posted on September 30th, 2012"Our invention is a skin care gel containing pectin nanoparticles, wound healing and anti-microbial agents. The proposed wound dressing involves positively or negatively charged polymers which cover and protect the wound surface. The employed nanoparticles enable a controlled release of the wound healing agent or the antimicrobial agent to the wound efficiently in course of time," Dr. Rassoul Dinarvand, PhD in pharmaceutics, Professor and Head of Faculty of Pharmacy and Medical Nanotechnology Research Center at Tehran University of Medical Sciences, told INIC.
"As a result, the wound healing process becomes faster and much easier by this method."
"A very simple and straightforward technique has been adopted to prepare pectin nanoparticles attached by the desired wound healing agents," he said, adding, "This synthesis method is solvent-free and, in contrast to the conventional methods used for the production of nanoparticles, does not entail sonication or homogenization which disrupts peptides and proteins in general."
"As the active ingredients of this product are enclosed inside a specific nanostructure, their release is well under control and obeys a pseudo-zeroth-order kinetics," Dr. Dinarvand said, underscoring the controlled release mechanism as a superior feature of the method.
He also appreciated the INIC for its financial support for the patenting process of the novel method, and stated that the INIC's financial incentive policies are most effectively encouraging Iranian inventors to patent their innovations globally.
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Govt.-Legislation/Regulation/Funding/Policy
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Discoveries
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||